[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371655-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371655-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","future-perspectives-and-conclusions-from-animal-models-of-chi3l1-related-inflammation-associated-cancer","Future Perspectives and Conclusions from Animal Models of CHI3L1-Related Inflammation-Associated Cancer","","Among molecules linked to inflammation-driven tumorigenesis, Chitinase 3-like 1 (CHI3L1/YKL-40/Brp-39) stands out as a strong target because of its roles in immune regulation, tissue remodeling, and cancer progression. Elevated CHI3L1 appears across human cancers and in animal models, where it enhances proliferation and angiogenesis and promotes immune evasion via an immunosuppressive inflamed microenvironment. Mechanisms involve STAT3, MAPK, and PI3K/Akt signaling and receptor interactions (IL-13Rα2, RAGE), with mouse models supporting a context-dependent relationship to tumor growth. Findings support CHI3L1 as a therapeutic target and diagnostic biomarker for inflammation-associated cancers, while underscoring the need for careful interpretation of animal evidence.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/future-perspectives-and-conclusions-from-animal-models-of-chi3l1-related-inflammation-associated-cancer/371655/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/future-perspectives-and-conclusions-from-animal-models-of-chi3l1-related-inflammation-associated-cancer/371655.png","ImageObject",300,407,{"name":42,"@type":43},"Nguyễn Văn Học","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is CHI3L1 considered a compelling target in inflammation-associated cancer?","Question",{"text":63,"@type":64},"CHI3L1 is implicated in immune regulation, tissue remodeling, and cancer progression. It promotes tumor proliferation and angiogenesis and helps establish an immunosuppressive environment in inflamed tissues.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does CHI3L1 influence signaling pathways and receptor interactions?",{"text":68,"@type":64},"The document describes CHI3L1 acting through modulation of STAT3, MAPK, and PI3K/Akt signaling pathways. It also interacts with cell surface receptors such as IL-13Rα2 and RAGE.",{"name":70,"@type":61,"acceptedAnswer":71},"What do transgenic and knockout mouse models show about CHI3L1 and tumor progression?",{"text":72,"@type":64},"Mouse model studies show a strong association between CHI3L1 expression and cancer progression. Overexpression correlates with increased tumor size and number in colon and lung cancer models, while deficiency suppresses tumor formation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371655,1791155019,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374402739827,"https://ap-avatar.wpscdn.com/avatar/14000c97e7351f1a627?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787885694763230660","Review  \nFuture Perspectives and Conclusions from Animal Models of CHI3L1‑Related Inflammation‑Associated Cancer  \nEmiko Mizoguchi 1,2, * and Siyuan Wang 1,3  \nAcademic Editor: Alexander E. Kalyuzhny  \nReceived: 3 June 2025  \nRevised: 21 June 2025  \nAccepted: 25 June 2025  \nPublished: 26 June 2025  \nCitation: Mizoguchi, E.; Wang, S. Future Perspectives and Conclusions from Animal Models of CHI3L1‑ Related Inflammation‑Associated Cancer. Cells 2025, 14, 982. [https://](https://)[ ](https://)[doi.org/10.3390/cells14130982](doi.org/10.3390/cells14130982)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Cell Biology, Kurume University School of Medicine, Fukuoka 8300011, Japan  \n2 Department of Molecular Microbiology and Immunology, Brown University Alpert Medical School, Providence, RI 02912, USA  \n3 Department of Cell Biology, Institute of Life Science, Kurume University, Fukuoka 8300011, Japan  \n* Correspondence: emizoguchi@kurume‑[u.ac.jp](u.ac.jp)  \nAbstract  \nAmong the molecules implicated in inflammation‑associated tumorigenesis, Chitinase 3‑ like 1 (CHI3L1/YKL‑40/Brp‑39) has emerged as a particularly compelling target due to its multifaced roles in immune regulation, tissue remodeling, and cancer progression. Ele‑ vated CHI3L1 expression is observed in various human cancers and corresponding an‑ imal models. CHI3L1 directly promotes tumor cell proliferation and angiogenesis and also contributes to immune evasion by establishing an immunosuppressive environment in inflamed tissues. Mechanistically, CHI3L1 exerts its effects through the modulation of STAT3, MAPK, and PI3K/Akt signaling pathways and by interacting with cell surface re‑ ceptors, such as IL‑13Rα2 and RAGE. Studies using transgenic and knockout mouse mod‑ els have revealed a strong association between CHI3L1 expression and cancer progression. In models of colon and lung cancer, CHI3L1 overexpression correlates with increased tu‑ mor size and number, whereas CHI3L1 deficiency markedly suppresses tumor formation. However, its involvement appears tobe context‑dependent and varies among different ep‑ ithelial tumor types. These findings suggest that CHI3L1 is a potential therapeutic target and diagnostic biomarker for inflammation‑associated cancers. Animal studies provide valuable insights into the immunological mechanisms of CHI3L1‑mediated tumorigenesis but also highlight the need for cautious interpretation due to inherent technical limitations.  \nKeywords: chitinase 3‑like 1; dysplasia; colitis; fibrosis; carcinogenesis  \n1. Introduction  \nThe association between chronic inflammation and cancer development was first pro‑ posed by the German pathologist Rudolf Virchow in the mid‑19th century [1] . He sug‑ gested that persistent inflammation resulting from tissue damage could create a microen‑ vironment conducive to tumorigenesis. Inflammatory cells actively release factors that promote cell proliferation, and when inflammation becomes chronic, it can lead to malig‑ nant transformation at the affected site. Chronic inflammation in specific organs, such asthe stomach, colon, and lungs, has been shown to significantly increase the risk of cancer in those tissues [2–7] . To sustain their growth, tumors manipulate the surrounding mi‑ croenvironment by recruiting macrophages and fibroblasts to form supportive scaffolds. They also secrete inflammatory cytokines and growth factors that promote angiogenesis and nutrient supply [8,9] .  \nInflammation is now recognized as a hallmark of cancer, with a complex and multi‑ faceted role in carcinogenesis. The initiation and progression of inflammation‑associated  \ncancers are closely linked to various factors, i","cbCaisGi72StYTtG","https://ap.wps.com/l/cbCaisGi72StYTtG","pdf",1019645,18,"English","# Abstract\n# Introduction\n## Chronic inflammation and cancer development\n## Chitin, chitinases, and chitinase-like proteins\n## CHI3L1 as a multifunctional biomarker and effector","[{\"question\":\"Why is CHI3L1 considered a compelling target in inflammation-associated cancer?\",\"answer\":\"CHI3L1 is implicated in immune regulation, tissue remodeling, and cancer progression. It promotes tumor proliferation and angiogenesis and helps establish an immunosuppressive environment in inflamed tissues.\"},{\"question\":\"How does CHI3L1 influence signaling pathways and receptor interactions?\",\"answer\":\"The document describes CHI3L1 acting through modulation of STAT3, MAPK, and PI3K/Akt signaling pathways. It also interacts with cell surface receptors such as IL-13Rα2 and RAGE.\"},{\"question\":\"What do transgenic and knockout mouse models show about CHI3L1 and tumor progression?\",\"answer\":\"Mouse model studies show a strong association between CHI3L1 expression and cancer progression. Overexpression correlates with increased tumor size and number in colon and lung cancer models, while deficiency suppresses tumor formation.\"}]","Future Perspectives and Conclusions from Animal Models of CHI3L1-Related Inflammation-Associated Cancer | PDF",1790192542,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b0e54cd46e31c0faab8346009b2f006f.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e4f12d289322a2eae94b7c3b1f6cd050.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1da39d4abf23d5da0e9f4eac72834e7e.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/19cd6ca30cf6ef68d11700b7a636e209.webp",980,1385]